Gilead Sciences said on Saturday that it entered into a partnership with Denmark’s LEO Pharma to develop programs to treat patients with inflammatory diseases.
Trending
- A win for Chelsea, FIFA and Trump – DW – 07/13/2025
- Dozens killed in sectarian clashes – DW – 07/14/2025
- Palmer stars as Chelsea stun PSG to win FIFA Club World Cup final
- Port Talbot moves towards arc furnace future with groundbreaking ceremony
- Gisele Pelicot awarded France’s highest civilian honor – DW – 07/14/2025
- Looking for clues on US consumer sentiment during Amazon 'Prime Week'
- De nieuwe tijdloze herenkleding voor lente/zomer 2026
- Jonathan Bailey On Jeff Goldblum’s Advice For ‘Jurassic World Rebirth’
Gilead, LEO Pharma partner to develop programs for inflammatory diseases
By Reuters Econ
